CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial Door to Balloon Time: Is There a Point That Is Too Short? Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial The Wait for High-Sensitivity Troponin Is Over—Proceed Cautiously Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support

Clinical TrialAugust 2019 Vol 12, Issue 8

JOURNAL:Circ Cardiovasc Interv. Article Link

Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome: A Pilot Randomized Controlled Trial

Lee MM, Petrie MC, Rocchiccioli P et al. Keywords: invasive vs medical management; CABG history; non-ST elevated ACS

FULL TEXT PDF